Net Profit increased by 43% to INR 126 crores in Q4 FY24 and 35% to INR 553 crores in FY24 JB Chemicals & Pharmaceuticals ltd (JB Pharma), one of the fastest growing pharmaceutical companies in India, announced its financial results for the quarter and year ended
In response to the growing need for specialized pediatric care, Gleneagles Hospital Mumbai is pleased to announce the expansion of its Bone Marrow Transplant (BMT) program to include dedicated services for pediatric patients. This initiative aims to provide comprehensive BMT services catering specifically to children,
Editor’s Synopsis: The collaboration aims to bolster healthcare entrepreneurship. IIHMR Start-up will extend its expertise to foster innovation in Clinical Research, Device Validation, Technology Implementation, and CSR support. IIHMR Start-ups, a pioneering initiative under the esteemed IIHMR Foundation, is delighted to announce the signing of Memorandum
Wanbury Ltd., one of India’s fastest growing pharmaceutical company having a presence in API global market and domestic branded Formulation, announced its financial results for the fourth quarter and year ended March 31, 2024. Consolidated Q4 & FY24 Financial Highlights
Need to add 30 lakh new hospital beds; aim to reach 100% health insurance coverage to achieve India’s healthcare vision 2047 Mr Apurva Chandra, Secretary, Health & Family Welfare, Government of India today released the FICCI-EY report - ‘Decoding India’s Healthcare Landscape’. The report highlights
By: Dr Arjun AL, MBBS, Vice President, DailyRounds, Bengaluru, India As the global medical landscape continues to evolve, the United Kingdom remains an attractive destination for Indian medical graduates (IMGs) seeking to expand their horizons and pursue career opportunities abroad. The surge in international medical graduates joining
Health experts from one of the leading healthcare providers, Paras Health, are sounding the alarm on the growing epidemic of youth hypertension, with added sugars, especially from sugar-sweetened beverages. Recent studies have shown a clear link between excessive sugar intake and elevated blood pressure in
Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%|0.5%. Glenmark’s Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%|0.5% has been determined by the FDA to be bioequivalent
The appointment is effective as of May 16, 2024. In her new role, Annapurna will lead the Company in India, ensuring patient access to its highly innovative medicines and vaccines, and advancing valuable collaborations to contribute to the growing domestic healthcare and pharmaceutical market. (TSE:4502/NYSE:TAK) Takeda Biopharmaceuticals
Emoha, India's premier eldercare brand, celebrates five years of revolutionizing the eldercare space with the launch of a groundbreaking initiative. Fuelled by a recent funding, Emoha is poised to extend its reach to the senior citizen segment of India's population. In a landmark move, Emoha
